| Income Statement |
| Operating Expenses | 7.00M |
|
| Research and Development Expense | 5.35M |
| Selling, General and Administrative Expense | 1.56M |
| Operating Income | -7.00M |
| Net Income | -3.38M |
| Net Income Common Stock | -3.38M |
| Net Income Common Stock (USD) | -3.38M |
| Consolidated Income | -3.38M |
| Earnings per Basic Share | -0.01 |
| Earnings per Basic Share (USD) | -0.01 |
| Earnings per Diluted Share | -0.01 |
| Earning Before Interest & Taxes (EBIT) | -3.38M |
| Earning Before Interest & Taxes (USD) | -3.38M |
| Weighted Average Shares | 261.64M |
| Weighted Average Shares Diluted | 261.64M |
| Balance Sheet |
| Cash and Equivalents | 60.44M |
| Cash and Equivalents (USD) | 60.44M |
| Investments | 50.00M |
| Investments Current | 50.00M |
| Trade and Non-Trade Receivables | 1.44M |
| Current Assets | 112.57M |
| Property, Plant & Equipment Net | 55.38M |
| Total Assets | 167.95M |
| Current Liabilities | 2.44M |
| Total Liabilities | 2.44M |
| Accumulated Retained Earnings (Deficit) | -278.91M |
| Accumulated Other Comprehensive Income | -3.28M |
| Shareholders Equity | 165.51M |
| Shareholders Equity (USD) | 165.51M |
| Assets Non-Current | 55.38M |
| Trade and Non-Trade Payables | 1.69M |
| Cash Flow |
| Net Cash Flow from Financing | 1.00 |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.25M |
| Net Cash Flow from Operations | -2.07M |
| Effect of Exchange Rate Changes on Cash | -2.18M |
| Share Based Compensation | 732.62K |